These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 12081250)

  • 41. Elimination of onchocerciasis in Africa by 2025: the need for a broad perspective.
    Cupp E; Sauerbrey M; Cama V; Eberhard M; Lammie PJ; Unnasch TR
    Infect Dis Poverty; 2019 Jul; 8(1):50. PubMed ID: 31303176
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Control of onchocerciasis.
    Boatin BA; Richards FO
    Adv Parasitol; 2006; 61():349-94. PubMed ID: 16735169
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Eliminating onchocerciasis as a public health problem: the beginning of the end.
    Etya'alé D
    Br J Ophthalmol; 2002 Aug; 86(8):844-6. PubMed ID: 12140199
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ten years of NGDO action against river blindness.
    Drameh PS; Richards FO; Cross C; Etya'alé DE; Kassalow JS
    Trends Parasitol; 2002 Sep; 18(9):378-80. PubMed ID: 12377246
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessment of the performance of community-directed treatment with ivermectin strategy for the control and elimination of onchocerciasis in Edo State, Nigeria.
    Onowhakpor AO; Okojie OH; Wagbatsoma VA
    Indian J Public Health; 2017; 61(4):267-273. PubMed ID: 29219132
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mectizan as a stimulus for development of novel partnerships: the international organization's perspective.
    Etya'alé DE
    Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S73-7. PubMed ID: 9861271
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Onchodermatitis.
    Murdoch ME
    Curr Opin Infect Dis; 2010 Apr; 23(2):124-31. PubMed ID: 20071985
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Controlling onchocerciasis by community-directed, ivermectin-treatment programmes in Uganda: why do some communities succeed and others fail?
    Katabarwa NM; Mutabazi D; Richards FO
    Ann Trop Med Parasitol; 2000 Jun; 94(4):343-52. PubMed ID: 10945044
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Factors affecting the attrition of community-directed distributors of ivermectin, in an onchocerciasis-control programme in the Imo and Abia states of south-eastern Nigeria.
    Emukah EC; Enyinnaya U; Olaniran NS; Akpan EA; Hopkins DR; Miri ES; Amazigo U; Okoronkwo C; Stanley A; Rakers L; Richards FO; Katabarwa MN
    Ann Trop Med Parasitol; 2008 Jan; 102(1):45-51. PubMed ID: 18186977
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Partnership and promise: evolution of the African river-blindness campaigns.
    Benton B; Bump J; Sékétéli A; Liese B
    Ann Trop Med Parasitol; 2002 Mar; 96 Suppl 1():S5-14. PubMed ID: 12081251
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Economic evaluation of Mectizan distribution.
    Waters HR; Rehwinkel JA; Burnham G
    Trop Med Int Health; 2004 Apr; 9(4):A16-25. PubMed ID: 15078276
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Feasibility of measuring compliance to annual ivermectin treatment in the African Programme for Onchocerciasis Control.
    Brieger WR; Okeibunor JC; Abiose AO; Ndyomugyenyi R; Kisoka W; Wanji S; Elhassan E; Amazigo UV
    Trop Med Int Health; 2007 Feb; 12(2):260-8. PubMed ID: 17300634
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of health education on community participation in rapid assessment of onchocerciasis prior to distribution of ivermectin.
    Shu EN; Nwadike KI; Onwujekwe EO; Ugwu OC; Okonkwo PO
    East Afr Med J; 1999 Jun; 76(6):320-3. PubMed ID: 10750518
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Progress towards the elimination of onchocerciasis as a public-health problem in Uganda: opportunities, challenges and the way forward.
    Ndyomugyenyi R; Lakwo T; Habomugisha P; Male B
    Ann Trop Med Parasitol; 2007 Jun; 101(4):323-33. PubMed ID: 17524247
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Community-directed, ivermectin-treatment programmes for onchocerciasis control in Uganda: the selection and validation of indicators for monitoring sustainability at the district level.
    Katabarwa MN; Mutabazi D
    Ann Trop Med Parasitol; 1999 Sep; 93(6):653-8. PubMed ID: 10707110
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Onchocerciasis control in the Democratic Republic of Congo (DRC): challenges in a post-war environment.
    Makenga Bof JC; Maketa V; Bakajika DK; Ntumba F; Mpunga D; Murdoch ME; Hopkins A; Noma MM; Zouré H; Tekle AH; Katabarwa MN; Lutumba P
    Trop Med Int Health; 2015 Jan; 20(1):48-62. PubMed ID: 25302560
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Economic impact of onchocerciasis control through the African Programme for Onchocerciasis Control: an overview.
    Benton B
    Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S33-9. PubMed ID: 9861265
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Onchocerciasis control in Nigeria: will households be able to afford community-directed treatment with ivermectin?
    Onwujekwe O; Shu E; Onwuameze O; Ndum C; Okonkwo P
    Acta Trop; 2001 Dec; 80(3):277-81. PubMed ID: 11700186
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Community-directed treatment with ivermectin in two Nigerian communities: an analysis of first year start-up processes, costs and consequences.
    Onwujekwe O; Chima R; Shu E; Okonkwo P
    Health Policy; 2002 Oct; 62(1):31-51. PubMed ID: 12151133
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Knowledge, attitude and practice of community drug distributors' about onchocerciasis and community directed treatment with ivermectin in Quara district, North Western Ethiopia.
    Weldegebreal F; Medhin G; Weldegebriel Z; Legesse M
    BMC Res Notes; 2016 Apr; 9():206. PubMed ID: 27053243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.